NIH conference. Factor VIII.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001792:Blood Platelets / Q000502:physiology; D001803:Blood Transfusion; D055598:Chemical Phenomena; D002621:Chemistry; D005169:Factor VIII / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000502:physiology*; D005260:Female; D006467:Hemophilia A / Q000175:diagnosis / Q000235:genetics / Q000628:therapy; D006801:Humans; D007231:Infant, Newborn; D046911:Macromolecular Substances; D008297:Male; D008875:Middle Aged; D010974:Platelet Aggregation / Q000187:drug effects; D012310:Ristocetin / Q000494:pharmacology; D014842:von Willebrand Diseases / Q000175:diagnosis / Q000235:genetics / Q000628:therapy; D014841:von Willebrand Factor / Q000378:metabolism / Q000502:physiology
D046911:Macromolecular Substances; D014841:von Willebrand Factor; D012310:Ristocetin; D005169:Factor VIII